The antibacterial activity of LL-37 against Treponema denticola is dentilisin protease independent and facilitated by the major outer sheath protein virulence factor

Infection and Immunity

Volumn 80, Issue 3, 2012, Pages 1107-1114

  Rosen, Graciela ^a   Sela, Michael N ^a   Bachrach, Gilad ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; DENTILISIN; MEMBRANE PROTEIN; PROTEINASE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIABILITY; BACTERICIDAL ACTIVITY; CELL ADHESION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG BINDING; ENZYMATIC DEGRADATION; HUMAN; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SALIVA; TREPONEMA DENTICOLA;

ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL PROTEINS; CHYMOTRYPSIN; GENE DELETION; HUMANS; MICROBIAL SENSITIVITY TESTS; PORINS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; TREPONEMA DENTICOLA; VIRULENCE FACTORS;

EID: 84857677420     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05903-11     Document Type: Article

References (80)

1. Bachrach G, et al. 2008. Resistance of Porphyromonas gingivalis ATCC 33277 to direct killing by antimicrobial peptides is protease independent. Antimicrob. Agents Chemother. 52:638-642.
2. Bachrach G, et al. 2006. Salivary LL-37 secretion in individuals with Down syndrome is normal. J. Dent. Res. 85:933-936.
3. Bergsson G, et al. 2009. LL-37 complexation with glycosaminoglycans in cystic fibrosis lungs inhibits antimicrobial activity, which can be restored by hypertonic saline. J. Immunol. 183:543-551.
4. Bernard JJ, Gallo RL. 2011. Protecting the boundary: the sentinel role of host defense peptides in the skin. Cell. Mol. Life Sci. 68:2189-2199.
5. Blakemore RP, Canale-Parola E. 1976. Arginine catabolism by Treponema denticola. J. Bacteriol. 128:616-622.
6. Brissette CA, Lukehart SA. 2007. Mechanisms of decreased susceptibility to beta-defensins by Treponema denticola. Infect. Immun. 75:2307-2315.
7. Brissette CA, Lukehart SA. 2002. Treponema denticola is resistant to human beta-defensins. Infect. Immun. 70:3982-3984.
8. Burton MF, Steel PG. 2009. The chemistry and biology of LL-37. Nat. Prod. Rep. 26:1572-1584.
9. Capone R, et al. 2008. Human serum antibodies recognize Treponema denticola Msp and PrtP protease complex proteins. Oral Microbiol. Immunol. 23:165-169.
10. Chi B, Qi M, Kuramitsu HK. 2003. Role of dentilisin in Treponema denticola epithelial cell layer penetration. Res. Microbiol. 154:637-643.
11. Chromek M, et al. 2006. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med. 12:636-641.
12. Cole JN, et al. 2010. M protein and hyaluronic acid capsule are essential for in vivo selection of covRS mutations characteristic of invasive serotype M1T1 group A Streptococcus. mBio 1:e00191-10.
13. Correia FF, et al. 2003. Two paralogous families of a two-gene subtilisin operon are widely distributed in oral treponemes. J. Bacteriol. 185:6860-6869.
14. Curtis MA, et al. 2011. Temperature-dependent modulation of Porphyromonas gingivalis lipid A structure and interaction with the innate host defenses. Infect. Immun. 79:1187-1193.
15. de Haar SF, Hiemstra PS, van Steenbergen MT, Everts V, Beertsen W. 2006. Role of polymorphonuclear leukocyte-derived serine proteinases in defense against Actinobacillus actinomycetemcomitans. Infect. Immun. 74:5284-5291.
16. Devine DA, Cosseau C. 2008. Host defense peptides in the oral cavity. Adv. Appl. Microbiol. 63:281-322.
17. Devine DA, Marsh PD, Percival RS, Rangarajan M, Curtis MA. 1999. Modulation of antibacterial peptide activity by products of Porphyromonas gingivalis and Prevotella spp. Microbiology 145(Pt 4):965-971.
18. Diamond G, Beckloff N, Weinberg A, Kisich KO. 2009. The roles of antimicrobial peptides in innate host defense. Curr. Pharm. Des. 15:2377-2392.
19. Edwards AM, Jenkinson HF, Woodward MJ, Dymock D. 2005. Binding properties and adhesion-mediating regions of the major sheath protein of Treponema denticola ATCC 35405. Infect. Immun. 73:2891-2898.
20. Egli C, Leung WK, Muller KH, Hancock RE, McBride BC. 1993. Pore-forming properties of the major 53-kilodalton surface antigen from the outer sheath of Treponema denticola. Infect. Immun. 61:1694-1699.
21. Ellen RP, Dawson JR, Yang PF. 1994. Treponema denticola as a model for polar adhesion and cytopathogenicity of spirochetes. Trends Microbiol. 2:114-119.
22. Enghild JJ, Salvesen G, Thogersen IB, Pizzo SV. 1989. Proteinase binding and inhibition by the monomeric α-macroglobulin rat α1-inhibitor-3. J. Biol. Chem. 264:11428-11435.
23. Epand RF, Wang G, Berno B, Epand RM. 2009. Lipid segregation explains selective toxicity of a series of fragments derived from the human cathelicidin LL-37. Antimicrob. Agents Chemother. 53:3705-3714.
24. Fenno JC, et al. 1998. Cytopathic effects of the major surface protein and the chymotrypsinlike protease of Treponema denticola. Infect. Immun. 66:1869-1877.
25. Fenno JC, Muller KH, McBride BC. 1996. Sequence analysis, expression, and binding activity of recombinant major outer sheath protein (Msp) of Treponema denticola. J. Bacteriol. 178:2489-2497.
26. Fenno JC, Wong GW, Hannam PM, McBride BC. 1998. Mutagenesis of outer membrane virulence determinants of the oral spirochete Treponema denticola. FEMS Microbiol. Lett. 163:209-215.
27. Fenno JC, et al. 1997. Conservation of msp, the gene encoding the major outer membrane protein of oral Treponema spp. J. Bacteriol. 179:1082-1089.
28. Gaibani P, et al. 2010. The central region of the msp gene of Treponema denticola has sequence heterogeneity among clinical samples, obtained from patients with periodontitis. BMC Infect. Dis. 10:345.
29. Gorr SU. 2009. Antimicrobial peptides of the oral cavity. Periodontol. 2000 51:152-180.
30. Grenier D. 1996. Degradation of host protease inhibitors and activation of plasminogen by proteolytic enzymes from Porphyromonas gingivalis and Treponema denticola. Microbiology 142(Pt 4):955-961.
31. Gron H, Meldal M, Breddam K. 1992. Extensive comparison of the substrate preferences of two subtilisins as determined with peptide substrates which are based on the principle of intramolecular quenching. Biochemistry 31:6011-6018.
32. Gupta S, et al. 2010. Fusobacterium nucleatum-associated beta-defensin inducer (FAD-I): identification, isolation, and functional evaluation. J. Biol. Chem. 285:36523-36531.
33. Gutner M, Chaushu S, Balter D, Bachrach G. 2009. Saliva enables the antimicrobial activity of LL-37 in the presence of proteases of Porphyromonas gingivalis. Infect. Immun. 77:5558-5563.
34. Haapasalo M, Muller KH, Uitto VJ, Leung WK, McBride BC. 1992. Characterization, cloning, and binding properties of the major 53-kilodalton Treponema denticola surface antigen. Infect. Immun. 60:2058-2065.
35. Imamura T. 2003. The role of gingipains in the pathogenesis of periodontal disease. J. Periodontol. 74:111-118.
36. Ishihara K, Kuramitsu HK, Miura T, Okuda K. 1998. Dentilisin activity affects the organization of the outer sheath of Treponema denticola. J. Bacteriol. 180:3837-3844.
37. Ishihara K, Miura T, Kuramitsu HK, Okuda K. 1996. Characterization of the Treponema denticola prtP gene encoding a prolyl-phenylalaninespecific protease (dentilisin). Infect. Immun. 64:5178-5186.
38. Ji S, et al. 2007. Susceptibility of various oral bacteria to antimicrobial peptides and to phagocytosis by neutrophils. J. Periodontal Res. 42:410-419.
39. Joly S, Maze C, McCray PB, Jr, Guthmiller JM. 2004. Human betadefensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J. Clin. Microbiol. 42:1024-1029.
40. Kigure T, et al. 1995. Distribution of Porphyromonas gingivalis and Treponema denticola in human subgingival plaque at different periodontal pocket depths examined by immunohistochemical methods. J. Periodontal Res. 30:332-341.
41. Kolenbrander PE, Parrish KD, Andersen RN, Greenberg EP. 1995. Intergeneric coaggregation of oral Treponema spp. with Fusobacterium spp. and intrageneric coaggregation among Fusobacterium spp. Infect. Immun. 63:4584-4588.
42. Koziel J, et al. 2010. Proteolytic inactivation of LL-37 by karilysin, a novel virulence mechanism of Tannerella forsythia. J. Innate Immun. 2:288-293.
43. Lee SH, Jun HK, Lee HR, Chung CP, Choi BK. 2010. Antibacterial and lipopolysaccharide (LPS)-neutralising activity of human cationic antimicrobial peptides against periodontopathogens. Int. J. Antimicrob. Agents 35:138-145.
44. Li J, et al. 2004. Identification of early microbial colonizers in human dental biofilm. J. Appl. Microbiol. 97:1311-1318.
45. Loesche WJ, Grossman NS. 2001. Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment. Clin. Microbiol. Rev. 14:727-752.
46. Lugtenberg B, Van Alphen L. 1983. Molecular architecture and functioning of the outer membrane of Escherichia coli and other gram-negative bacteria. Biochim. Biophys. Acta 737:51-115.
47. Mäkinen KK, Makinen PL. 1996. The peptidolytic capacity of the spirochete system. Med. Microbiol. Immunol. 185:1-10.
48. Mäkinen KK, Mäkinen PL, Loesche WJ, Syed SA. 1995. Purification and general properties of an oligopeptidase from Treponema denticola ATCC 35405-a human oral spirochete. Arch. Biochem. Biophys. 316:689-698.
49. Mäkinen PL, Mäkinen KK, Syed SA. 1994. An endo-acting prolinespecific oligopeptidase from Treponema denticola ATCC 35405: evidence of hydrolysis of human bioactive peptides. Infect. Immun. 62:4938-4947.
50. Mäkinen PL, Mäkinen KK, Syed SA. 1995. Role of the chymotrypsin-like membrane-associated proteinase from Treponema denticola ATCC 35405 in inactivation of bioactive peptides. Infect. Immun. 63:3567-3575.
51. Markland FJ, Smith E. 1971. Subtilisins: primary structure, chemical and physical properties, p 561-608. In Boyer PD (ed), The Enzymes, 3rd ed, vol 3. Academic Press, New York, NY.
52. Mathers DA, Leung WK, Fenno JC, Hong Y, McBride BC. 1996. The major surface protein complex of Treponema denticola depolarizes and induces ion channels in HeLa cell membranes. Infect. Immun. 64:2904-2910.
53. McDowell JV, et al. 2011. Identification of the primary mechanism of complement evasion by the periodontal pathogen, Treponema denticola. Mol. Oral Microbiol. 26:140-149.
54. Murakami M, Lopez-Garcia B, Braff M, Dorschner RA, Gallo RL. 2004. Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J. Immunol. 172:3070-3077.
55. Nizet V, et al. 2001. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414:454-457.
56. Nussbaum G, Ben-Adi S, Genzler T, Sela MN, Rosen G. 2009. Involvement of Toll-like receptors 2 and 4 in the innate immune response to Treponema denticola and its outer sheath components. Infect. Immun. 77:3939-3947.
57. Oren Z, Lerman JC, Gudmundsson GH, Agerberth B, Shai Y. 1999. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its noncell-selective activity. Biochem. J. 341(Pt 3):501-513.
58. Perona JJ, Craik CS. 1995. Structural basis of substrate specificity in the serine proteases. Protein Sci. 4:337-360.
59. Poulos TL, Alden RA, Freer ST, Birktoft JJ, Kraut J. 1976. Polypeptide halomethyl ketones bind to serine proteases as analogs of the tetrahedral intermediate. X-ray crystallographic comparison of lysine-and phenylalanine-polypeptide chloromethyl ketone-inhibited subtilisin. J. Biol. Chem. 251:1097-1103.
60. Puklo M, Guentsch A, Hiemstra PS, Eick S, Potempa J. 2008. Analysis of neutrophil-derived antimicrobial peptides in gingival crevicular fluid suggests importance of cathelicidin LL-37 in the innate immune response against periodontogenic bacteria. Oral Microbiol. Immunol. 23:328-335.
61. Putsep K, Carlsson G, Boman HG, Andersson M. 2002. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 360:1144-1149.
62. Rosen G, Genzler T, Sela MN. 2008. Coaggregation of Treponema denticola with Porphyromonas gingivalis and Fusobacterium nucleatum is mediated by the major outer sheath protein of Treponema denticola. FEMS Microbiol. Lett. 289:59-66.
63. Rosen G, Naor R, Kutner S, Sela MN. 1994. Characterization of fibrinolytic activities of Treponema denticola. Infect. Immun. 62:1749-1754.
64. Rosen G, Naor R, Rahamim E, Yishai R, Sela MN. 1995. Proteases of Treponema denticola outer sheath and extracellular vesicles. Infect. Immun. 63:3973-3979.
65. Rother M, Bock A, Wyss C. 2001. Selenium-dependent growth of Treponema denticola: evidence for a clostridial-type glycine reductase. Arch. Microbiol. 177:113-116.
66. Sambri V, et al. 2002. Comparative in vitro activity of five cathelicidinderived synthetic peptides against Leptospira, Borrelia and Treponema pallidum. J. Antimicrob. Chemother. 50:895-902.
67. Serhan CN, Chiang N, Van Dyke TE. 2008. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8:349-361.
68. Seshadri R, et al. 2004. Comparison of the genome of the oral pathogen Treponema denticola with other spirochete genomes. Proc. Natl. Acad. Sci. U. S. A. 101:5646-5651.
69. Shah HN, Gharbia SE, Zhang MI. 1993. Measurement of electrical bioimpedance for studying utilization of amino acids and peptides by Porphyromonas gingivalis, Fusobacterium nucleatum, and Treponema denticola. Clin. Infect. Dis. 16(Suppl. 4):S404-S407.
70. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL, Jr. 1998. Microbial complexes in subgingival plaque. J. Clin. Periodontol. 25:134-144.
71. Soren L, Nilsson M, Nilsson LE. 1995. Quantitation of antibiotic effects on bacteria by bioluminescence, viable counting and quantal analysis. J. Antimicrob. Chemother. 35:669-674.
72. Sun X, Salih E, Oppenheim FG, Helmerhorst EJ. 2009. Activity-based mass spectrometric characterization of proteases and inhibitors in human saliva. Proteomics Clin. Appl. 3:810-820.
73. Turkoglu O, Emingil G, Kutukculer N, Atilla G. 2009. Gingival crevicular fluid levels of cathelicidin LL-37 and interleukin-18 in patients with chronic periodontitis. J. Periodontol. 80:969-976.
74. Uitto VJ, Grenier D, Chan EC, McBride BC. 1988. Isolation of a chymotrypsinlike enzyme from Treponema denticola. Infect. Immun. 56:2717-2722.
75. Wang Q, Ko KS, Kapus A, McCulloch CA, Ellen RP. 2001. A spirochete surface protein uncouples store-operated calcium channels in fibroblasts: a novel cytotoxic mechanism. J. Biol. Chem. 276:23056-23064.
76. Wilm M, Mann M. 1996. Analytical properties of the nanoelectrospray ion source. Anal. Chem. 68:1-8.
77. Yamada M, Ikegami A, Kuramitsu HK. 2005. Synergistic biofilm formation by Treponema denticola and Porphyromonas gingivalis. FEMS Microbiol. Lett. 250:271-277.
78. Zasloff M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395.
79. Zasloff M. 2002. Innate immunity, antimicrobial peptides, and protection of the oral cavity. Lancet 360:1116-1117.
80. Zhou Q, Leeman SE, Amar S. 2011. Signaling mechanisms in the restoration of impaired immune function due to diet-induced obesity. Proc. Natl. Acad. Sci. U. S. A. 108:2867-2872.